Atlas Trials

HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).

Clinical trial NCT04472845 · RECRUITING

Trial details

NCT number
NCT04472845
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast CancerHypofractionationRadiotherapy Side Effect
Start date
2021-03-30
Primary completion
2023-08-20
Enrollment
1018

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.